Literature DB >> 24050653

Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.

Yongjun Gao1, Kenneth J Kellar, Robert P Yasuda, Thao Tran, Yingxian Xiao, Robert F Dannals, Andrew G Horti.   

Abstract

A new series of derivatives of 3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)dibenzo[b,d]thiophene 5,5-dioxide with high binding affinities and selectivity for α7-nicotinic acetylcholine receptors (α7-nAChRs) (Ki = 0.4-20 nM) has been synthesized for positron emission tomography (PET) imaging of α7-nAChRs. Two radiolabeled members of the series [(18)F]7a (Ki = 0.4 nM) and [(18)F]7c (Ki = 1.3 nM) were synthesized. [(18)F]7a and [(18)F]7c readily entered the mouse brain and specifically labeled α7-nAChRs. The α7-nAChR selective ligand 1 (SSR180711) blocked the binding of [(18)F]7a in the mouse brain in a dose-dependent manner. The mouse blocking studies with non-α7-nAChR central nervous system drugs demonstrated that [(18)F]7a is highly α7-nAChR selective. In agreement with its binding affinity the binding potential of [(18)F]7a (BPND = 5.3-8.0) in control mice is superior to previous α7-nAChR PET radioligands. Thus, [(18)F]7a displays excellent imaging properties in mice and has been chosen for further evaluation as a potential PET radioligand for imaging of α7-nAChR in non-human primates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050653      PMCID: PMC3866913          DOI: 10.1021/jm401184f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  58 in total

Review 1.  Development of radioligands for the imaging of α7 nicotinic acetylcholine receptors with positron emission tomography.

Authors:  Peter Brust; Dan Peters; Winnie Deuther-Conrad
Journal:  Curr Drug Targets       Date:  2012-05       Impact factor: 3.465

Review 2.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

Review 3.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

4.  Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand.

Authors:  Lei Zhang; Anabella Villalobos; Elizabeth M Beck; Thomas Bocan; Thomas A Chappie; Laigao Chen; Sarah Grimwood; Steven D Heck; Christopher J Helal; Xinjun Hou; John M Humphrey; Jiemin Lu; Marc B Skaddan; Timothy J McCarthy; Patrick R Verhoest; Travis T Wager; Kenneth Zasadny
Journal:  J Med Chem       Date:  2013-05-28       Impact factor: 7.446

5.  [125I]Iodomethyllycaconitine binds to alpha7 nicotinic acetylcholine receptors in monkey brain.

Authors:  Jennifer M Kulak; F Ivy Carroll; Jay S Schneider
Journal:  Eur J Neurosci       Date:  2006-05       Impact factor: 3.386

6.  Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.

Authors:  E M Meyer; A Kuryatov; V Gerzanich; J Lindstrom; R L Papke
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

7.  Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.

Authors:  Mikako Ogawa; Shingo Nishiyama; Hideo Tsukada; Kentaro Hatano; Takeshi Fuchigami; Hiroshi Yamaguchi; Yoshitaka Matsushima; Kengo Ito; Yasuhiro Magata
Journal:  Nucl Med Biol       Date:  2010-01-15       Impact factor: 2.408

Review 8.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

9.  Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.

Authors:  Jennifer M Kulak; Jay S Schneider
Journal:  Brain Res       Date:  2004-03-05       Impact factor: 3.252

Review 10.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

View more
  20 in total

1.  Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.

Authors:  Dean F Wong; Hiroto Kuwabara; Martin Pomper; Daniel P Holt; James R Brasic; Noble George; Boris Frolov; William Willis; Yongjun Gao; Heather Valentine; Ayon Nandi; Lorena Gapasin; Robert F Dannals; Andrew G Horti
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

2.  [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

Authors:  Yongjun Gao; Ronnie C Mease; Thao T Olson; Kenneth J Kellar; Robert F Dannals; Martin G Pomper; Andrew G Horti
Journal:  Nucl Med Biol       Date:  2014-12-20       Impact factor: 2.408

3.  Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson's Disease.

Authors:  Steven Vetel; Johnny Vercouillie; Frédéric Buron; Jackie Vergote; Clovis Tauber; Julie Busson; Gabrielle Chicheri; Sylvain Routier; Sophie Sérrière; Sylvie Chalon
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

4.  PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.

Authors:  Ansel T Hillmer; Songye Li; Ming-Qiang Zheng; Matthias Scheunemann; Shu-Fei Lin; Nabeel Nabulsi; Daniel Holden; Richard Pracitto; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Irina Esterlis; Kelly P Cosgrove; Peter Brust; Richard E Carson; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-24       Impact factor: 9.236

Review 5.  Opportunities in precision psychiatry using PET neuroimaging in psychosis.

Authors:  Jennifer M Coughlin; Andrew G Horti; Martin G Pomper
Journal:  Neurobiol Dis       Date:  2019-03-20       Impact factor: 5.996

6.  18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.

Authors:  Andrew G Horti; Yongjun Gao; Hiroto Kuwabara; Yuchuan Wang; Sofya Abazyan; Robert P Yasuda; Thao Tran; Yingxian Xiao; Niaz Sahibzada; Daniel P Holt; Kenneth J Kellar; Mikhail V Pletnikov; Martin G Pomper; Dean F Wong; Robert F Dannals
Journal:  J Nucl Med       Date:  2014-02-20       Impact factor: 10.057

Review 7.  Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.

Authors:  Alina Kassenbrock; Neil Vasdev; Steven H Liang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.

Authors:  Andrew G Horti
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

9.  The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM.

Authors:  Jennifer M Coughlin; Yong Du; Hailey B Rosenthal; Stephanie Slania; Soo Min Koo; Andrew Park; Ghedem Solomon; Melin Vranesic; Inga Antonsdottir; Caroline L Speck; Kelly Rootes-Murdy; Alexandria Lerner; Steven P Rowe; Yuchuan Wang; Wojciech G Lesniak; Il Minn; Arnold Bakker; Gwenn S Smith; Robert F Dannals; Hiroto Kuwabara; Andrew Horti; Dean F Wong; Martin G Pomper
Journal:  Neuroimage       Date:  2017-10-07       Impact factor: 6.556

10.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.